APA (7th ed.) Citation

Li, J., Peng, L., Du, H., Wang, Y., Lu, B., Xu, Y., . . . Shao, J. The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats. Wiley.

Chicago Style (17th ed.) Citation

Li, Jie, Li Peng, Hong Du, Yangtian Wang, Bin Lu, Yixin Xu, Xiaozhen Ye, and Jiaqing Shao. The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy Through the Inhibition of the P38 MAPK Signaling Pathway in High-Fat-Induced SD Rats. Wiley.

MLA (9th ed.) Citation

Li, Jie, et al. The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy Through the Inhibition of the P38 MAPK Signaling Pathway in High-Fat-Induced SD Rats. Wiley.